Goldman Sachs Group Inc Penumbra Inc Call Options Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$220.09 - $273.15 $66,027 - $81,945
300 Added 1.71%
17,800 $3.97 Million
Q3 2023

Nov 14, 2023
BUY
$240.69 - $338.77 $3.8 Million - $5.35 Million
15,800 Added 929.41%
17,500 $4.23 Million
Q1 2023

May 14, 2024
SELL
$220.43 - $278.69 $3.48 Million - $4.4 Million
-15,800 Reduced 90.29%
1,700 $473,000
Q1 2023

May 11, 2023
BUY
$220.43 - $278.69 $374,731 - $473,773
1,700 New
1,700 $473,000

Others Institutions Holding PEN

# of Institutions
381
Shares Held
29.6M
Call Options Held
285K
Put Options Held
168K
View Full List

About Penumbra Inc

PEN Quotes by TradingView
  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $8.68B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email